| Current Price | $119.55 | Mkt Cap | $11.2B |
|---|---|---|---|
| Open | $117.32 | P/E Ratio | -11.59 |
| Prev. Close | $119.55 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $117.27 - $119.80 | Volume | 838,200 |
| 52-Wk Range | $100.15 - $159.89 | Avg. Daily Vol. | 1,052,654 |
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
| Current Price | $119.55 | Mkt Cap | $11.2B |
|---|---|---|---|
| Open | $117.32 | P/E Ratio | -11.59 |
| Prev. Close | $119.55 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $117.27 - $119.80 | Volume | 838,200 |
| 52-Wk Range | $100.15 - $159.89 | Avg. Daily Vol. | 1,052,654 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong revenue growth and a big pipeline make this a good long-term hold.
Short. Biopharma. Sells more stock than has revenues. Revs declining too.
Read the most recent pitches from players about SRPT.
Recs
TMFjimhalley
(< 20)
Submitted: 8/25/2022 2:50:04 PM :
Start Price:
$114.44
NASDAQ:SRPT Score:
+0.86
Strong revenue growth and a big pipeline make this a good long-term hold.
Recs
EKO01
(< 20)
Submitted: 5/28/2020 3:50:26 PM :
Start Price:
$153.80
NASDAQ:SRPT Score:
-64.60
srpt is the future of gene therapy in rare diseases. at the same time it is already strong today with very interesting pipeline and excellent management. momentum (post covid) + secular growt = sustainable growth and important gains. watch out but don't worry about volatility.
Recs
TMFEBCapital
(72.70)
Submitted: 1/28/2019 1:49:05 PM :
Start Price:
$117.60
NASDAQ:SRPT Score:
-62.19
Potential to increase total addressable market from 13% to to 30% of Duchenne muscular dystrophy population by the end of 2020.
Find the members with the highest scoring picks in SRPT.
Newt805 (58.14) Score: +2,561.07
"It's one thing to feel that you're on the right path, but it's another to think that yours is the only path." Paulo Cuelho, novelist IX X XIII XIV XL XLIII
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
Newt805 | 58.14 |
|
|
5Y | $4.14 | +2,786.84% | +225.77% | +2,561.07 | 3 Comments |
| ruben7086 | < 20 | 5/10/2012 |
|
5Y | $4.80 | +2,390.62% | +215.62% | +2,175.00 | 0 Comment | |
| rustam5 | 56.20 | 4/18/2012 |
|
5Y | $5.40 | +2,113.89% | +210.49% | +1,903.40 | 0 Comment | |
| embodiedheart | 28.71 | 4/2/2012 |
|
5Y | $6.54 | +1,727.98% | +203.48% | +1,524.51 | 0 Comment | |
| Apprentice15 | 86.20 | 2/8/2012 |
|
3M | $6.54 | +1,727.98% | +219.05% | +1,508.93 | 0 Comment | |
| blashmet | < 20 | 2/8/2012 |
|
5Y | $6.78 | +1,663.27% | +219.88% | +1,443.39 | 0 Comment | |
| benjaeger | 59.92 | 8/8/2011 |
|
1Y | $6.90 | +1,632.61% | +268.99% | +1,363.62 | 0 Comment | |
| Prof3215 | < 20 | 9/16/2011 |
|
5Y | $7.50 | +1,494.00% | +255.67% | +1,238.33 | 1 Comment | |
| TheMadFlea | < 20 | 3/22/2012 |
|
5Y | $8.16 | +1,365.07% | +209.95% | +1,155.12 | 0 Comment | |
| DudeTri | 42.57 | 6/13/2011 |
|
5Y | $8.10 | +1,375.93% | +237.31% | +1,138.61 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
